They also combined the results of four endometrial cancer cohorts, where LLS represented 52% (95% CI: 41–62%) of the patients with a dMMR endometrial cancer tested for germline MMR gene variations (101 patients in total after the exclusion of tumors with MLH1 hypermethylation). The gene discussed is MRC1; the disease is endometrial cancer.